Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 942443
                    [Title] => Menarini provides Pinoys with innovative, affordable drugs for cardiovascular diseases
                    [Summary] => 
Italy’s leading research-based pharmaceutical company Menarini is committed to providing Filipino patients with innovative and affordable treatment options for cardiovascular diseases, the leading cause of death in the Philippines.

                    [DatePublished] => 2013-05-16 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 838599
                    [Title] => Invida launches beta blocker with dual action for hypertension, heart failure
                    [Summary] => 
Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive heart failure (CHF).
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

NEBIVOLOL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 942443
                    [Title] => Menarini provides Pinoys with innovative, affordable drugs for cardiovascular diseases
                    [Summary] => 
Italy’s leading research-based pharmaceutical company Menarini is committed to providing Filipino patients with innovative and affordable treatment options for cardiovascular diseases, the leading cause of death in the Philippines.

                    [DatePublished] => 2013-05-16 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 838599
                    [Title] => Invida launches beta blocker with dual action for hypertension, heart failure
                    [Summary] => 
Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive heart failure (CHF).
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Menarini provides Pinoys with innovative, affordable drugs for cardiovascular diseases

May 16, 2013 - 12:00am

Italy’s leading research-based pharmaceutical company Menarini is committed to providing Filipino patients with innovative and affordable treatment options for cardiovascular diseases, the leading cause of...

Science and Environment

Invida launches beta blocker with dual action for hypertension, heart failure

August 16, 2012 - 12:00am

Invida Philippines, the local subsidiary of leading Italian research-based pharmaceutical group Menarini, has launched Nebivolol, a highly cardioselective beta blocker that effectively treats hypertension and congestive...

Science and Environment